Back to Search Start Over

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia

Authors :
Marcus J. Schultz
Maeke J. Scheerder
Abraham Goorhuis
Ludo F. M. Beenen
Saskia Middeldorp
Alexander P.J. Vlaar
N.H.J. Lobé
J.G. van den Aardweg
Marcella C.A. Müller
Lieuwe D. J. Bos
P.I. Bonta
Graduate School
Radiology and Nuclear Medicine
ACS - Microcirculation
ACS - Pulmonary hypertension & thrombosis
ANS - Neurovascular Disorders
AGEM - Amsterdam Gastroenterology Endocrinology Metabolism
ARD - Amsterdam Reproduction and Development
Intensive Care Medicine
Pulmonology
Infectious diseases
AII - Infectious diseases
APH - Aging & Later Life
APH - Global Health
Vascular Medicine
AMS - Sports
ACS - Heart failure & arrhythmias
ACS - Diabetes & metabolism
Source :
Thrombosis Research, Radiology, Thrombosis research, 196, 135-137. Elsevier Limited
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

Purpose To introduce the COVID-19 Reporting and Data System (CO-RADS) for standardized assessment of pulmonary involvement of COVID-19 on non-enhanced chest CT and report its initial interobserver agreement and performance. Methods The Dutch Radiological Society (NVvR) developed CO-RADS based on other efforts for standardization, such as Lung-RADS or BI-RADS. CO-RADS assesses the suspicion for pulmonary involvement of COVID-19 on a scale from 1 (very low) to 5 (very high). The system is meant to be used in patients presenting with moderate to severe symptoms of COVID-19. The system was evaluated using 105 chest CTs of patients admitted to the hospital with clinical suspicion of COVID-19 in whom RT-PCR was performed (62 +/- 16 years, 61 men, 53 with positive RT-PCR). Eight observers assessed the scans using CO-RADS. Fleiss’ kappa was calculated, and scores of individual observers were compared to the median of the remaining seven observers. The resulting area under the receiver operating characteristics curve (AUC) was compared to results from RT-PCR and clinical diagnosis of COVID-19. Results There was absolute agreement among observers in 573 (68.2%) of 840 observations. Fleiss’ kappa was 0.47 (95% confidence interval (CI) 0.45-0.47), with the highest kappa for CO-RADS categories 1 (0.58, 95% CI 0.54-0.62) and 5 (0.68, 95% CI 0.65-0.72). The average AUC was 0.91 (95% CI 0.85-0.97) for predicting RT-PCR outcome and 0.95 (95% CI 0.91-0.99) for clinical diagnosis. The false negative rate for CO-RADS 1 was 9/161 (5.6%, 95% CI 1.0-10%), and the false positive rate for CO-RADS 5 was 1/286 (0.3%, 95% CI 0-1.0%). Conclusions CO-RADS is a categorical assessment scheme for pulmonary involvement of COVID-19 on non-enhanced chest CT providing very good performance for predicting COVID-19 in patients with moderate to severe symptoms and has a substantial interobserver agreement, especially for categories 1 and 5.

Details

Language :
English
ISSN :
00493848
Database :
OpenAIRE
Journal :
Thrombosis Research
Accession number :
edsair.doi.dedup.....95f844d29b6775c845643f8eca2cb584
Full Text :
https://doi.org/10.1016/j.thromres.2020.08.026